1.Establishment of Modified Brain Death Model in Pig
Chenguang WAN ; Xuequan FENG ; Mu LI ; Hongying DU ; Weiye ZHANG ; Yuan SHI ; Lei LIU ; Zhongyang SHEN
Tianjin Medical Journal 2014;(4):318-320
Objective To establish a stable and reliable model of brain death in swine, and to provide a more stable model for investigating pathomorphology in brain tissue and for studying transplantation immunology during brain death. Methods Base on the classic methodology of increasing epidural intracranial pressure, Codman intracranial pressure moni-toring probes were implanted in landrace pigs invasively. According to the relationship between ICP and MAP, brain death models were established by increasing intracranial pressure slowly and intermittently, with real-time monitoring of the intra-cranial pressure. Results Among twelve experimental landrace pigs, one died from anesthetic accident, while the rest elev-en were successfully established as brain death models. With effective respiratory and circulatory support, those brain death models can be maintained for (31.3 ± 4.7) h. Brain death model establishement is a stable and reliable process demonstrated by transcranial Doppler, EEG, ECG, mean arterial blood pressure and other monitoring methods. After brain death is con-firmed, animal models can be maintained for a long time. Conclusion Our methodology of inducing brain death model un-der ICP monitoring is stable and easy to be standardized. It can also provide a more stable model for studying brain tissue pathomorphology and transplantation immunology.
2.Microsurgical treatment of pontine cavernous malformations via transtelovelar approach: a clinical analysis of 12 cases
Hui ZHOU ; Fuyuan WANG ; Weiye SUN ; Hui SHI
Chinese Journal of Neuromedicine 2016;15(10):1056-1059
Objective To explore the surgical treatment strategies,advantages and surgical indications of pontine cavernous malformations (CMs) through transtelovelar approach.Methods This study included 12 patients with pontine CMs,admitted to our hospital from January 2009 to December 2014.The clinical data of these patients were retrospective study.Results All patients received microsurgical treatment to remove the pontine CMs located in the back of pons through transtelovelar approach.The total resection was achieved in all 12 patients.Follow up was performed for 4 to 36 months,no death case was noted.Postoperative complications of worsening original symptom were noted in one patient and new neurological symptoms in one.Conclusions The transtelovelar approach can provide adequate exposure to remove the brainstem CMs located in the back of pons.Long-term follow up indicates satisfactory efficacy and prognosis of microsurgical treatment.
3.Determination of 9 components Simultaneously in Swertia chirayita by HPLC method
Yuan SU ; Zengliang YANG ; Anping LIU ; Xueliang LIU ; Haiqing LIU ; Kaixiang WANG ; Chunlan SHI ; Weiye LI ; Wensheng XU ; Cunsheng ZOU
International Journal of Traditional Chinese Medicine 2023;45(5):594-599
Objective:To establish a HPLC method for determinating 9 components simultaneously in Swertia chirayita. Methods:By useing water Sunfire C18 column (4.6 mm× 250 mm,5 μm); Gradient elution was carried out with methanol-0.05% phosphoric acid solution as mobile phase. Setting the column temperature at 30 ℃, the flow rate at 1.0 ml/min, and the detection wavelength at 254 nm.Results:9 components showed good linear relationship within the injection quality range. The recovery rates of wertiamarin, Gentiopicroside, Angelica glycosides,Mangiferin, Isolysine, Gentianoside, Diol glycoside, 8-hydroxy-1,3,5 trimethoxyketone, and Daisy leaf gentinone were 95.38%, 92.41%, 95.14%, 91.87%, 92.24%, 92.51%, 95.08%, 91.72%, 95.74% ( n=6). Conclusion:The method is simple, efficient, sensitive, accurate, economical and practical, with repeatability and stability. It could provide reference for the quality control and comprehensive utilization of Swertia chirayita.
4.The effects and possible mechanisms of SRSF7 on the proliferation, migration, and invasion of HepG2 cells
SHI Weiye ; YAO Xu ; FU Yu ; CAO Yirao ; WANG Yingze
Chinese Journal of Cancer Biotherapy 2024;31(9):864-870
[摘 要] 目的:探讨富含丝氨酸/精氨酸剪接因子7(SRSF7)对肝细胞癌(HCC)细胞HepG2增殖、迁移和侵袭的影响及其可能机制。方法:通过癌症基因组图谱(TCGA)和Kaplan-Meier Plotter在线分析SRSF7在HCC和癌旁组织中的差异表达及其与患者预后的关系。常规培养HepG2细胞,用转染试剂将SRSF7 RNA敲减序列(siSRSF7#1和siSRSF7#2)、对照序列(NC)、SRSF7过表达载体(hSRSF7-oe)和对照载体(hSRSF7-nc)转染至HepG2细胞中,实验分为NC组、siSRSF7#1组、siSRSF7#2组、NC + hSRSF7-nc组、siSRSF7 + hSRSF7-nc组和siSRSF7 + hSRSF7-oe组。通过qPCR和WB法检测各组HepG2细胞中SRSF7 mRNA和蛋白的表达,MTS实验、平板克隆形成实验、划痕愈合实验、Transwell小室实验分别检测各组HepG2细胞的增殖、迁移和侵袭的能力。WB法检测各组HepG2细胞中JAK1/STAT3信号通路的相关蛋白的表达。结果:数据库数据分析显示SRSF7 mRNA在HCC组织中呈高表达(P < 0.001),SRSF7 mRNA高表达与HCC患者不良预后有关联(P < 0.05)。敲减SRSF7后,HepG2细胞的增殖、迁移和侵袭能力均显著下降(均P < 0.01)。敲减SRSF7组细胞中JAK1和STAT3磷酸化水平显著降低(均P < 0.05),同时过表达SRSF7后,JAK1和STAT3磷酸化水平又明显升高(均P < 0.05)。结论:SRSF7在HCC组织中呈高表达,其可能通过调控JAK1/STAT3信号通路促进HepG2细胞的增殖、迁移和侵袭。